AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25391047 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 182
Study 22459647 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (group C)
Number of subjects: 0
Study 22459647 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture without electrical stimulation (group B)
Number of subjects: 0
Study 22459647 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment (group A)
Number of subjects: 0
Study 19692415 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligofructose-enriched inulin (ORAFTI®Synergy 1)
Number of subjects: 0
Study 19692415 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 18021825 — intervention group
Group type: COMPARATOR
Intervention: Composite resin (Z100 MP) (control group)
Number of subjects: 40
Study 18021825 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobalt‐chromium ceramic alloy custom‐made cast post and core (IPS d.SIGN 30; CCPC group)
Number of subjects: 40
Study 18021825 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon fiber post system (Tech Xop 2000; CFP group)
Number of subjects: 40
Study 16055396 — intervention group
Group type: EXPERIMENTAL
Intervention: Autofluorescence bronchoscopy (AF)
Number of subjects: 36
Study 16055396 — intervention group
Group type: EXPERIMENTAL
Intervention: White-light bronchoscopy (WL) combined with p53 analysis
Number of subjects: 36
Study 16055396 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of WL, AF, and p53 mutation analysis
Number of subjects: 36
Study 16055396 — intervention group
Group type: EXPERIMENTAL
Intervention: Histopathology
Number of subjects: 36
Study 16055396 — intervention group
Group type: EXPERIMENTAL
Intervention: All methods (WL, AF, p53)
Number of subjects: 36
Study 12383074 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal strength training (three times a week for 8 weeks, using a cable pulley at 85% of one repetition maximum)
Number of subjects: 19
Study 12383074 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal strength training
Number of subjects: 19
Study 10193106 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental blackcurrant juice drink with calcium
Number of subjects: 12
Study 10193106 — intervention group
Group type: COMPARATOR
Intervention: Orange juice
Number of subjects: 12
Study 10193106 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study 8788691 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral skills training
Number of subjects: 31
Study 8788691 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive case management
Number of subjects: 31
Study 8788691 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-Step recovery
Number of subjects: 31
Study 8788691 — intervention group
Group type: COMPARATOR
Intervention: Men in the same sample
Number of subjects: 31
Study 1688065 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone and procaterol (Group A)
Number of subjects: 80
Study 1688065 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone and procaterol (Group B)
Number of subjects: 80
Study 1688065 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Group C)
Number of subjects: 80
Study 6119777 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg twice daily for 4 weeks
Number of subjects: 50
Study 6119777 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 50
Study 6119777 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine after initial treatment
Number of subjects: 50
Study 6119777 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine after initial placebo treatment
Number of subjects: 50
Study 31358470 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week walking intervention aimed at increasing daily steps
Number of subjects: 59
Study 31358470 — intervention group
Group type: EXPERIMENTAL
Intervention: Days with higher than average activity
Number of subjects: 59
Study 31358470 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-impact physical activity (walking)
Number of subjects: 59
Study 28394081 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+LLLT (non-smokers with chronic periodontitis)
Number of subjects: 30
Study 28394081 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+Sham (non-smokers with chronic periodontitis)
Number of subjects: 30
Study 28394081 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+LLLT (smokers with chronic periodontitis)
Number of subjects: 30
Study 28394081 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP+Sham (smokers with chronic periodontitis)
Number of subjects: 30
Study 26415995 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with cediranib
Number of subjects: 296
Study 26415995 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 296
Study 23516092 — intervention group
Group type: EXPERIMENTAL
Intervention: Gushen Pian (double-blind treatment group)
Number of subjects: 120
Study 23516092 — intervention group
Group type: COMPARATOR
Intervention: Placebo (double-blind control group)
Number of subjects: 120
Study 23516092 — intervention group
Group type: EXPERIMENTAL
Intervention: Gushen Pian (simple treatment group)
Number of subjects: 120
Study 21829616 — intervention group
Group type: EXPERIMENTAL
Intervention: T. suis eggs (2500 eggs every 21 days for 168 days, total 8 doses)
Number of subjects: 96
Study 21829616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 19230605 — intervention group
Group type: EXPERIMENTAL
Intervention: Observed eating school meals
Number of subjects: 555
Study 19230605 — intervention group
Group type: COMPARATOR
Intervention: Not observed eating school meals
Number of subjects: 555
Study 17965790 — intervention group
Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 897
Study 17965790 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 897
Study 15491755 — intervention group
Group type: EXPERIMENTAL
Intervention: Precolposcopy counseling with further explanation and discussion with an experienced colposcopic nurse
Number of subjects: 220
Study 15491755 — intervention group
Group type: COMPARATOR
Intervention: No further discussion (control group)
Number of subjects: 220
Study 15491755 — intervention group
Group type: EXPERIMENTAL
Intervention: Precolposcopy counseling
Number of subjects: 220
Study 11528230 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow rate (Qb) 400 ml/min
Number of subjects: 4
Study 11528230 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow rate (Qb) 300 ml/min
Number of subjects: 4
Study 11528230 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow rate (Qb) 200 ml/min
Number of subjects: 4
Study 11528230 — intervention group
Group type: EXPERIMENTAL
Intervention: UM Kt/V
Number of subjects: 4
Study 9935259 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg trovafloxacin by mouth
Number of subjects: 200
Study 9935259 — intervention group
Group type: COMPARATOR
Intervention: 2 g cefoxitin by i.v. infusion
Number of subjects: 200
Study 7923666 — intervention group
Group type: EXPERIMENTAL
Intervention: Sematilide
Number of subjects: 33
Study 7923666 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 33
Study 3169282 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian stimulation with human menopausal gonadotropin (hMG) starting on day 2 of the cycle
Number of subjects: 173
Study 3169282 — intervention group
Group type: COMPARATOR
Intervention: Ovarian stimulation with human menopausal gonadotropin (hMG) starting on day 4 of the cycle
Number of subjects: 173
Study 31635477 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV biofeedback (BF) intervention, 4 training sessions
Number of subjects: 35
Study 31635477 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV biofeedback (BF) intervention
Number of subjects: 35
Study 31635477 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 35
Study 29565660 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus Oral Health 4 Life (OH4L)
Number of subjects: 718
Study 29565660 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 718
Study 28991280 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) administration during internal fracture reduction
Number of subjects: 20
Study 28991280 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PRP application)
Number of subjects: 20
Study 25689258 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracerebroventricular rhPDGF-BB (0.2, 1.5, or 5 μg per day)
Number of subjects: 12
Study 25689258 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracerebroventricular rhPDGF-BB
Number of subjects: 12
Study 25689258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 23860406 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to unpleasant music during stress exposure
Number of subjects: 14
Study 23860406 — intervention group
Group type: COMPARATOR
Intervention: Listening to pleasant music during stress exposure
Number of subjects: 14
Study 20634303 — intervention group
Group type: EXPERIMENTAL
Intervention: VBM-DARTEL
Number of subjects: 134
Study 20634303 — intervention group
Group type: COMPARATOR
Intervention: Conventional VBM
Number of subjects: 134
Study 20634303 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 134
Study 17970838 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue-directed biopsies (MB)
Number of subjects: 48
Study 17970838 — intervention group
Group type: COMPARATOR
Intervention: Conventional four-quadrant biopsies (4QB)
Number of subjects: 48
Study 15982790 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD 103-HgR live oral cholera vaccine
Number of subjects: 134
Study 15982790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 12852707 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin ER 80 mg QD
Number of subjects: 173
Study 12852707 — intervention group
Group type: COMPARATOR
Intervention: Fluvastatin IR 40 mg QD
Number of subjects: 173
Study 10665628 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 10 mg/day
Number of subjects: 650
Study 10665628 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg/day
Number of subjects: 650
Study 10665628 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 40 mg/day
Number of subjects: 650
Study 10665628 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 60 mg/day
Number of subjects: 650
Study 10665628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 650
Study 8604406 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day course of trimethoprim-sulfamethoxazole (Bactrim, Cotrim, Septra)
Number of subjects: 0
Study 8604406 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day course of trimethoprim alone (Proloprim, Trimpex)
Number of subjects: 0
Study 8604406 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous antimicrobial prophylaxis
Number of subjects: 0
Study 8604406 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of catheter-related infection
Number of subjects: 0
Study 8604406 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 to 6 weeks of therapy for infection in men
Number of subjects: 0
Study 1931469 — intervention group
Group type: EXPERIMENTAL
Intervention: CGRP (human alpha-CGRP)
Number of subjects: 6
Study 1931469 — intervention group
Group type: COMPARATOR
Intervention: Prostacyclin (PGI2)
Number of subjects: 6
Study 121636 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexitone and halothane
Number of subjects: 79
Study 121636 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam, IPPV, adequate analgesia and anaesthesia
Number of subjects: 79
Study 30980608 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 79288
Study 30980608 — intervention group
Group type: EXPERIMENTAL
Intervention: RAS blockers
Number of subjects: 79288
Study 30980608 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blockers
Number of subjects: 79288
Study 30980608 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers
Number of subjects: 79288
Study 28095795 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal magnesium sulfate (50 mg)
Number of subjects: 60
Study 28095795 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride (Control group)
Number of subjects: 60
Study 25875257 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized vaccine
Number of subjects: 2004
Study 25875257 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous vaccine
Number of subjects: 2004
Study 23498346 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy milk consumption
Number of subjects: 29
Study 23498346 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk consumption
Number of subjects: 29
Study 20521852 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep
Number of subjects: 0
Study 20521852 — intervention group
Group type: COMPARATOR
Intervention: Wakefulness
Number of subjects: 0
Study 19728561 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of fexofenadine
Number of subjects: 12
Study 19728561 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of fexofenadine
Number of subjects: 12
Study 19728561 — intervention group
Group type: EXPERIMENTAL
Intervention: Test and Reference formulations
Number of subjects: 12
Study 17019564 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone treatment for 4 weeks
Number of subjects: 20
Study 17019564 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control)
Number of subjects: 20
Study 17019564 — intervention group
Group type: EXPERIMENTAL
Intervention: DIP group (6 out of 8 symptomatic for PS at baseline)
Number of subjects: 20
Study 17019564 — intervention group
Group type: EXPERIMENTAL
Intervention: NoDIP group (2 out of 12 symptomatic for PS at baseline)
Number of subjects: 20
Study 17019564 — intervention group
Group type: EXPERIMENTAL
Intervention: DIP group
Number of subjects: 20
Study 17019564 — intervention group
Group type: EXPERIMENTAL
Intervention: NoDIP group
Number of subjects: 20
Study 15176652 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg methylphenidate extended-release capsule
Number of subjects: 24
Study 15176652 — intervention group
Group type: COMPARATOR
Intervention: 20 mg methylphenidate extended-release capsule (reference treatment)
Number of subjects: 24
Study 15176652 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg methylphenidate extended-release capsule
Number of subjects: 24
Study 11563193 — intervention group
Group type: EXPERIMENTAL
Intervention: Dan Shao Tang and western medicine
Number of subjects: 132
Study 11563193 — intervention group
Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 132
Study 9521953 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH treatment (mean dose 0.78 ± 0.12 IU/kg/week, subcutaneously 5 to 7 times per week for 2.2 ± 1.2 years)
Number of subjects: 123
Study 9521953 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH treatment
Number of subjects: 123
Study 8039024 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine (anaesthesia of the nose)
Number of subjects: 10
Study 8039024 — intervention group
Group type: COMPARATOR
Intervention: Allergen challenge (without nasal anaesthesia)
Number of subjects: 10
Study 2930092 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg of caffeine sodium benzoate)
Number of subjects: 13
Study 2930092 — intervention group
Group type: COMPARATOR
Intervention: Placebo (97% caffeine-free coffee)
Number of subjects: 13
Study 4151126 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicergolin
Number of subjects: 30
Study 4151126 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroergotoxine
Number of subjects: 30
Study 31958442 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral phrenic nerve stimulation
Number of subjects: 0
Study 31958442 — intervention group
Group type: EXPERIMENTAL
Intervention: Low flow oxygen
Number of subjects: 0
Study 31958442 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study 31958442 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 0
Study 31958442 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive servo ventilation (ASV)
Number of subjects: 0
Study 30901061 — intervention group
Group type: EXPERIMENTAL
Intervention: Purpuragenic PDL
Number of subjects: 27
Study 30901061 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplexed PDL/Nd:YAG
Number of subjects: 27
Study 30901061 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 27
Study 28555052 — intervention group
Group type: EXPERIMENTAL
Intervention: New Zealand blackcurrant (NZBC) extract (600 mg∙day‐1 CurraNZ™)
Number of subjects: 13
Study 28555052 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 13
Study 25485658 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program for 8 weeks with an additional 10-month maintenance period
Number of subjects: 42
Study 25485658 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program
Number of subjects: 42
Study 25485658 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study 23916915 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered behavioral intervention for diabetes and hypertension
Number of subjects: 377
Study 23916915 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 377
Study 21951520 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Enjoyment Scale (PACES)
Number of subjects: 0
Study 21951520 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened, 8-item version of PACES
Number of subjects: 0
Study 19233881 — intervention group
Group type: EXPERIMENTAL
Intervention: Video laryngoscopy
Number of subjects: 200
Study 19233881 — intervention group
Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 200
Study 17471830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic fields (PEMF) therapy
Number of subjects: 0
Study 17471830 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 15136103 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: 200 microL of air in the syringe, 100-125 microL of air in the proximal part of the catheter, 20-25 microL of medium containing the embryos, and 10 microL of air at the tip of the catheter
Number of subjects: 102
Study 15136103 — intervention group
Group type: COMPARATOR
Intervention: Group 2: Syringe and entire catheter filled with medium, embryo-containing medium aspirated without air spaces
Number of subjects: 102
Study 11797269 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (standard treatment)
Number of subjects: 0
Study 11797269 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of epirubicin-cisplatin-continuous 5FU (ECF)
Number of subjects: 0
Study 11797269 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio-chemotherapy
Number of subjects: 0
Study 11797269 — intervention group
Group type: EXPERIMENTAL
Intervention: 5FU alone, 5FU-cisplatin, or 5FU-mitomycin (as preoperative or exclusive treatment)
Number of subjects: 0
Study 9564481 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyronaridine
Number of subjects: 88
Study 9564481 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 88
Study 7817618 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg bisoprolol once daily
Number of subjects: 22
Study 7817618 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg lisinopril once daily
Number of subjects: 22
Study 3140739 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 22
Study 3140739 — intervention group
Group type: COMPARATOR
Intervention: Pancrease (control)
Number of subjects: 22
Study 30836363 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg lycopene, 5.8 mg phytoene and phytofluene, 0.8 mg β-carotene, 5.6 mg tocopherols from tomato extract, and 4 mg carnosic acid from rosemary extract per day
Number of subjects: 149
Study 30836363 — intervention group
Group type: COMPARATOR
Intervention: Placebo made from medium-chain triglycerides
Number of subjects: 149
Study 29179974 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 100 units/mL (Gla-100)
Number of subjects: 3586
Study 26807534 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischaemic Conditioning (RIC)
Number of subjects: 128
Study 26807534 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 128
Study 26807534 — intervention group
Group type: EXPERIMENTAL
Intervention: RIC
Number of subjects: 128
Study 25098959 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls Management Exercise (FaME) programme
Number of subjects: 1256
Study 25098959 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Programme (OEP)
Number of subjects: 1256
Study 25098959 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1256
Study 22054660 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral valve repair
Number of subjects: 0
Study 22054660 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral valve replacement
Number of subjects: 0
Study 19901144 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive computerized information (ICI)
Number of subjects: 135
Study 19901144 — intervention group
Group type: COMPARATOR
Intervention: Standard institutional verbal and written information (SI)
Number of subjects: 135
Study 17264106 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment group (4-session weekly caregiver programme)
Number of subjects: 39
Study 17264106 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment control group
Number of subjects: 39
Study 17264106 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment group
Number of subjects: 39
Study 16226510 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 IU ovine hyaluronidase
Number of subjects: 1362
Study 16226510 — intervention group
Group type: EXPERIMENTAL
Intervention: 55 IU ovine hyaluronidase
Number of subjects: 1362
Study 16226510 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 IU ovine hyaluronidase
Number of subjects: 1362